Abstract
Extracorporeal enzymatic detoxification for support of failing organ function requires long-term applicability of such enzymes for hours or even days. Different approaches towards this aim have been reported (Chang, 1969; Brunner and Jaworek, 1976; Schmer et al., 1981). The physiological detoxification of the majority of endogenous toxins requires phase I and phase II reactions and high energetic cofactors like uridine disphosphoglucuronic acid (UDPGA), nicotinamide adenine dinucleotide phosphate (reduced form, NADPH), nicotinamide adenine dinucleotide (reduced form, NADH), adenosine triphosphate (ATP), 5-adenosyl-L-methionine (SAM). Enzyme immobilisation was initially an essential step in using these enzymes in biological fluids to prevent immunological reactions. However, immobilisation results in a significant loss of enzyme activity and cofactor supply is a costly problem. Until now cofactors had to be constantly infused into the enzymatic reaction systems or agarose beads were soaked in cofactor solutions prior to application which allowed catalytic activities up to one hour. With both methods, large amounts of expensive cofactors were wasted. For long-term enzymatic detoxification reactions, as required in hepatic failure, for example, both methods are not suitable. Therefore, improved
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brunner, G., Holloway, C.J. and Lösgen, H. (1979). Large agarose beads for extracorporeal detoxification systems. Int.J.artif. Organs, 2(3), 163–169.
Brunner, G. and Jaworek, D. (1976). A new approach towards an extracorporeal management in liver failure. Use of detoxifying enzymes bound to artificial membranes, in C.M. Leevy (ed.), Diseases of the Liver and Biliary Tract, Karger, Basel, pp.39–41.
Brunner, G. and Tegtmeier, F. (1984). Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions. Artif.Organs, 8, 161–166.
Chang, T.M.S. (1969). Clinical potential of enzyme technology. Science Tools, 16, 461–469.
Halwachs, W., Völkel, W., Brunner, G. and Schügerl, K. (1981). Liquid membrane enzyme reactor for artificial liver support, in G. Brunner and F.W. Schmidt (eds.), Artificial Liver Support, Springer, Heidelberg, pp.219–229.
Holloway, C.J., Harstick, K. and Brunner, G. (1979). Agarose-encapsulated adsorbents. Int.J.artif.Organs, 2(2), 81–86.
Holloway, C.J., Husmann-Holloway, S. and Brunner, G. (1981). Assay of UDP-glucuronyltransferase with mixtures of acceptors using analytical capillary isotachophoresis. Electrophoresis, 2, 25–31.
Schmer, G., Newman, M.L., Rastelli, L., Dennis, M.B., Jr. and Henne, W. (1981). Synthesis of enzyme reactors consisting of xenocells. Trans.Am.Soc.artif.intern.Organs, 27, 544–546.
Tegtmeier, F. and Brunner, G. (1984). Adsorption and desorption characteristics of nucleotides on agarose encapsulated resins for long term cofactor supply of enzymatic reactions. Biomater.med.Devices artif.Organs (in press).
Editor information
Copyright information
© 1984 Bioengineering Unit, University of Strathclyde
About this chapter
Cite this chapter
Brunner, G., Tegtmeier, F. (1984). New Technologies For Extracorporeal Enzymatic Detoxification. In: Paul, J.P., Gaylor, J.D.S., Courtney, J.M., Gilchrist, T. (eds) Biomaterials in Artificial Organs. Strathclyde Bioengineering Seminars. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07283-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-349-07283-5_16
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07285-9
Online ISBN: 978-1-349-07283-5
eBook Packages: MedicineMedicine (R0)